Back to mobile site

Bank of America Downgrades MAP Pharmaceuticals (MAPP) to Neutral

February 10, 2009 7:38 AM EST Send to a Friend
Bank of America downgrades MAP Pharmaceuticals (Nasdaq: MAPP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login